FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Enric Pedrol

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Geographic Areas

Spain

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gabriel Vallecillo; Josep Mallolas; Enric Pedrol; Jesús Blanch; Manuel Cervantes; Pere Domingo; Elena Ferrer; Hernando Knobel; Josep M Llibre
Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.
Vicente Estrada; Manuel Fuentes-Ferrer; María José Galindo; Myriam Garrido; Paloma Geijo; José López Aldeguer; Fernando Lozano; Agustín Muñoz; Josefa Muñoz-Sánchez; Enric Pedrol; Teresa Puig; Esteve Ribera; Bernardino Roca; María Rodrigo; Trinitario Sánchez; María Luisa García Alcalde; Manuel Castaño-Carracedo; Jaime Cosín; Elisabeth Deig; Pere Domingo; Ramón Teira; Alberto Terrón; Antonio Vergara; Pompeyo E. Viciana; Francisco Vidal; Ignacio Suárez-Lozano
Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
M Perea; Oscar Miró; Meritxell Lluís; Enric Pedrol
[Do all patients who suffer from non-complicated acute pyelonephritis need to be hospitalized?].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Enric Pedrol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Gabriel Vallecillo; Josep Mallolas; Enric Pedrol; Jesús Blanch; Manuel Cervantes; Pere Domingo; Elena Ferrer; Hernando Knobel; Josep M Llibre
Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.
AIDS research and human retroviruses 2012;28(2):165-70.
2011: Vicente Estrada; Manuel Fuentes-Ferrer; María José Galindo; Myriam Garrido; Paloma Geijo; José López Aldeguer; Fernando Lozano; Agustín Muñoz; Josefa Muñoz-Sánchez; Enric Pedrol; Teresa Puig; Esteve Ribera; Bernardino Roca; María Rodrigo; Trinitario Sánchez; María Luisa García Alcalde; Manuel Castaño-Carracedo; Jaime Cosín; Elisabeth Deig; Pere Domingo; Ramón Teira; Alberto Terrón; Antonio Vergara; Pompeyo E. Viciana; Francisco Vidal; Ignacio Suárez-Lozano
Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
BMC women's health 2011;11():36.
2010: M Perea; Oscar Miró; Meritxell Lluís; Enric Pedrol
[Do all patients who suffer from non-complicated acute pyelonephritis need to be hospitalized?].
Revista clínica española 2010;210(7):366-7.
2010: Ramón Teira; Ignacio Suárez-Lozano; Fernando Lozano; Pompeyo E. Viciana; Pere Domingo; Pepa Galindo; Paloma Geijo; Alberto Terrón; Juan González; Jaime Cosín; Esteban Ribera; Bernardino Roca; María L García-Alcalde; Trinitario Sánchez; Agustín Muñoz-Sánchez; Antonio Vergara; José López Aldeguer; Enric Pedrol; Francesc Vidal; Myriam Garrido; Juan M Santamaría
Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.
Enfermedades infecciosas y microbiología clínica 2010;28(5):266-72.
2010: P Echeverría; Eugenia Negredo; G Carosi; J Gálvez; J L Gómez; A Ocampo; J Portilla; A Prieto; J C López; R Rubio; A Mariño; Enric Pedrol; Consuelo Viladés; A del Arco; A Moreno; I Bravo; R López-Blazquez; Núria Pérez-Alvarez; Bonaventura Clotet
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
Antiviral research 2010;85(2):403-8.
2010: Sergi Veloso; Montserrat Olona; Felipe García; Pere Domingo; Carlos Alonso-Villaverde; Montserrat Broch; Joaquim Peraire; Consuelo Viladés; Montserrat Plana; Enric Pedrol; Miguel López-Dupla; Carmen Aguilar; Mar Gutiérrez; Agathe Leon; Mariona Tasias; Josep Ma Gatell; Cristóbal Richart; Francesc Vidal
Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
BMC medical genetics 2010;11():63.
2009: Glòria Garrabou; Constanza Morén; Jose Miguel Gallego-Escuredo; Ana Milinkovic; Francesc Villarroya; Eugenia Negredo; Marta Giralt; Francesc Vidal; Enric Pedrol; Esteban Martínez; Francesc Cardellach; Josep Maria Gatell; Oscar Miró
Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemia.
Journal of acquired immune deficiency syndromes (1999) 2009;52(4):443-51.
2009: Beatriz Mothe; Iñaki Perez; Pere Domingo; Daniel Podzamczer; Esteban Ribera; Adrian Curran; Consuelo Viladés; Francesc Vidal; David Dalmau; Enric Pedrol; Eugenia Negredo; José Moltó; Roger Paredes; Núria Perez-Alvarez; Jose Maria Gatell; Bonaventura Clotet
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain.
Current HIV research 2009;7(6):597-600.
2009: Sebastián Hernández; Magdalena Vidal; Enric Pedrol
[Cardiovascular risk assessment and intervention in HIV-infected patients].
Enfermedades infecciosas y microbiología clínica 2009;27 Suppl 1():40-7.
2009: Josep Mallolas; Daniel Podzamczer; Ana Milinkovic; Pere Domingo; Bonaventura Clotet; Esteve Ribera; Félix Gutiérrez; Hernando Knobel; Jaime Cosin; Elena Ferrer; José Alberto Arranz; Victor Roca; Francesc Vidal; Javier Murillas; Judit Pich; Enric Pedrol; Josep M Llibre; David Dalmau; Isabel García; Miquel Aranda; Ana Cruceta; Esteban Martínez; José L Blanco; Elisa de Lazzari; José M Gatell
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):29-36.
2009: José Moltó; Josep Maria Llibre; Esteban Ribera; Carlos Mínguez; Jesús Sánchez del Río; Enric Pedrol; Gabriel Vallecillo; Samandhy Cedeño; Marta Valle; Cristina Miranda; Eugenia Negredo; Bonaventura Clotet
Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.
The Journal of antimicrobial chemotherapy 2009;63(5):992-7.
2009: Daniel Podzamczer; Montserrat Olmo; Jose Sanz; Vicente Boix; Eugenia Negredo; Hernando Knobel; Pere Domingo; Juan A Pineda; Consuelo Vilades; Jose Hernandez Quero; Lluis Force; Juan Gonzalez Lahoz; Pepa Muñoz; Josep M Llibre; Ana Mariño; Enrique Ortega; David Dalmau; Josep M Gatell; Esperanza Antón; Julio Sola; María J Galindo; Enric Pedrol; Jesus Sanz; Javier Torre de Lima; Juan Flores
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients.
Journal of acquired immune deficiency syndromes (1999) 2009;50(4):390-6.
2008: Juan Berenguer; Juan González; Esteban Ribera; Pere Domingo; Jesús Santos; Pilar Miralles; M Angels Ribas; Víctor Asensi; Juan Luis Gimeno; José Antonio Pérez-Molina; José Alberto Terrón; Juan Miguel Santamaría; Enric Pedrol
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1083-92.
2008: Vicenç Falcó; Montserrat Olmo; Sara Villar del Saz; Ana Guelar; José R Santos; Mar Gutiérrez; Daniel Colomer; Elisabet Deig; Gracia Mateo; Milagro Montero; Enric Pedrol; Daniel Podzamczer; Pere Domingo; Josep M Llibre
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
Journal of acquired immune deficiency syndromes (1999) 2008;49(1):26-31.
2008: Elena Ferrer; Jose Maria Gatell; Pochita Sanchez; Pere Domingo; Teresa Puig; Jordi Niubo; Cristina Cortes; Sergio Veloso; Enric Pedrol; Agathe Leon; Mar Gutierrez; Daniel Podzamczer
Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot study.
AIDS research and human retroviruses 2008;24(7):931-4.
2008: Josep Mallolas; Judith Pich; María Peñaranda; Pere Domingo; Hernando Knobel; Enric Pedrol; Félix Gutiérrez; Pilar Barrufet; Joaquim Peraire; Miguel A Asenjo; Francesc Vidal; José M Gatell
Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults.
AIDS (London, England) 2008;22(3):377-84.
2007: Enric Pedrol; Elisabet Deig
Reply to Crane et al., 'Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir'.
AIDS (London, England) 2007;21(18):2566.
2007: Josep Mallolas; José L Blanco; J Pich; Juan A Arnaiz; J M Peña; David Dalmau; Elisa De Lazzari; A Ochoa; Francesc Vidal; M A Ribas; Ferran Segura; Enric Pedrol; J Flores; Anna Cruceta; S Varea; José M Miró; Esteban Martínez; José M Gatell
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
Revista clínica española 2007;207(9):427-32.
2007: Enric Pedrol; Teodoro Martín; Miguel Angel del Pozo; Juan Flores; José Sanz; José A Cartón; Juan-José Jusdado; Piedad Arazo; Esteban Ribera; Elisabet Deig
[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].
Medicina clínica 2007;129(10):361-5.
2007: Joaquim Peraire; Oscar Miró; Maria Saumoy; Pere Domingo; Enric Pedrol; Francesc Villarroya; Esteban Martínez; Miguel López-Dupla; Glòria Garrabou; Maria Antonia Sambeat; Elisabet Deig; Joan Villarroya; Matilde R Chacón; Sònia López; Angels Fontanet; Maija Holmstrom; Marta Giralt; José M Gatell; Francesc Vidal
HIV-1-infected long-term non-progressors have milder mitochondrial impairment and lower mitochondrially-driven apoptosis in peripheral blood mononuclear cells than typical progressors.
Current HIV research 2007;5(5):467-73.
2007: Consuelo Viladés; Montserrat Broch; Montserrat Plana; Pere Domingo; Carlos Alonso-Villaverde; Enric Pedrol; Hernando Knobel; David Dalmau; Joaquim Peraire; Cristina Gutiérrez; Anna López; Maria Antonia Sambeat; Montserrat Olona; Felipe Garcia; Cristóbal Richart; José M Gatell; Francesc Vidal
Effect of genetic variants of CCR2 and CCL2 on the natural history of HIV-1 infection: CCL2-2518GG is overrepresented in a cohort of Spanish HIV-1-infected subjects.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):132-8.
2007: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; María Leyes; Enric Pedrol; Lluís Force; Elisa De Lazzari; José M Gatell
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients.
AIDS (London, England) 2007;21(3):367-9.
2006: Anna Soler; Elisabet Deig; Josep Guil; Marisa Rodríguez-Martín; Ana Guelar; Enric Pedrol
[Effectiveness and tolerance of atorvastatin for antiretroviral therapy-secondary dyslipemia].
Medicina clínica 2006;127(7):250-2.
2006: Joaquim Peraire; Montserrat Broch; Pere Domingo; Enric Pedrol; David Dalmau; Hernando Knobel; Consuelo Viladés; Maria Antonia Sambeat; Cristóbal Richart; Francesc Vidal
Absence of CXCR4 C-terminal polymorphisms in HIV-1-infected and uninfected Spaniards.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):382-3.
2006: Andrés Marco; Elisabet Deig; Josep Cadafalch; Montserrat Fuster; Inmaculada Valls; Enric Pedrol
[Clinical and pharmacokinetic interactions between methadone and nelfinavir (Nemesia study)].
Medicina clínica 2006;127(2):47-50.
2006: Glòria Miró; Enric Pedrol; Anna Soler; Mateu Serra-Prat; Juan C Yébenes; Rafael Martínez; José Antonio Capdevila
[Knowledge of the disease and the advance directives in patients with HIV infection].
Medicina clínica 2006;126(15):567-72.
2006: Anna Bonjoch; Roger Paredes; Pere Domingo; Manel Cervantes; Enric Pedrol; Esteban Ribera; Lluís Force; Josep M Llibre; Josep Vilaró; David Dalmau; Josep Cucurull; Jaume Mascaró; Angels Masabeu; Núria Pérez-Alvarez; Jordi Puig; Denise Cinquegrana; Bonaventura Clotet
Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.
AIDS research and human retroviruses 2006;22(4):321-9.
2006: Rosa Polo; M José Galindo; Esteban Martínez; Julia Alvarez; José Manuel Arévalo; Victor Asensi; Dolores Cánoves; Emilia Cáncer; Julio Collazos; Vicente Estrada; Carmen Gómez-Candela; Susan Johnston; Jaime Locutura; José López Aldeguer; Fernando Lozano; Celia Miralles; Agustín Muñoz-Sanz; Enrique Ortega; Javier Pascua; Enric Pedrol; Federico Pulido; Miguel San Martín; Jesús Sanz; Pompeyo E. Viciana; Lourdes Chamorro
[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].
Enfermedades infecciosas y microbiología clínica 2006;24(2):96-117.
2006: Oscar Miró; Glòria Garrabou; Sònia López; Elisabet Deig; Immaculada Vidal; Ana B Infante; Francesc Cardellach; Jordi Casademont; Enric Pedrol
Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.
Antiviral therapy 2006;11(5):625-30.
2006: Daniel Fuster; Ramon Planas; Juan Gonzalez; Lluís Force; Manel Cervantes; Josep Vilaró; Mercè Roget; Isabel García; Enric Pedrol; Jordi Tor; Angel Luis Ballesteros; Anna Salas; Guillem Sirera; Sebastián Videla; Bonaventura Clotet; Cristina Tural
Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
Antiviral therapy 2006;11(4):473-82.
2006: Francesc Vidal; Joaquim Peraire; Pere Domingo; Montserrat Broch; Mireia Cairó; Enric Pedrol; Milagros Montero; Consuelo Viladés; Cristina Gutiérrez; Maria Antonia Sambeat; Angels Fontanet; David Dalmau; Elisabet Deig; Hernando Knobel; Joan-Josep Sirvent; Cristóbal Richart; Sergi Veloso; Maria Saumoy; Miguel López-Dupla; Montserrat Olona; Josep Cadafalch; Montserrat Fuster; Anna Ochoa; Anna Soler; Ana Guelar; Judit González
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):17-22.
2005: Francesc Vidal; Consuelo Viladés; Pere Domingo; Montserrat Broch; Enric Pedrol; David Dalmau; Hernando Knobel; Joaquim Peraire; Cristina Gutiérrez; Maria Antonia Sambeat; Angels Fontanet; Elisabet Deig; Mireia Cairó; Milagros Montero; Cristóbal Richart; Simon Mallal
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele.
Journal of acquired immune deficiency syndromes (1999) 2005;40(5):527-31.
2005: Francesc Vidal; Joaquim Peraire; Pere Domingo; Montserrat Broch; Hernando Knobel; Enric Pedrol; David Dalmau; Consuelo Viladés; Maria Antonia Sambeat; Cristina Gutiérrez; Cristóbal Richart
Lack of association of SDF-1 3'A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 years.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):276-9.
2005: Oscar Miró; Sònia López; Joaquim Fernández-Solà; Glòria Garrabou; Enric Pedrol; Eva Badia; Esteban Martínez; Francesc Cardellach; José M Gatell; Jordi Casademont
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle.
AIDS research and human retroviruses 2005;21(8):702-5.
2005: Enric Pedrol; Mónica Ribell; Elisabet Deig; María del Carmen Villà; Oscar Miró; Glòria Garrabou; Anna Soler
[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors].
Medicina clínica 2005;125(6):201-4.
2005: Oscar Miró; Joan Villarroya; Glòria Garrabou; Sònia López; M Luisa Rodríguez de la Concepción; Enric Pedrol; Esteban Martínez; Marta Giralt; José M Gatell; Francesc Cardellach; Jordi Casademont; Francesc Villarroya
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.
Antiviral therapy 2005;10(8):945-51.
2005: Daniel Fuster; Jaime A Huertas; Guadalupe Gómez; Ricard Solà; Juan González García; Josep Vilaró; Enric Pedrol; Lluís Force; Jordi Tor; Guillem Sirera; Sebastián Videla; Ramon Planas; Bonaventura Clotet; Cristina Tural
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.
Antiviral therapy 2005;10(7):841-7.
2005: Esteban Ribera; Dolors Rodríguez Pardo; Manuel Rubio; Anna Soler; Enric Pedrol; José L Blanco; Alicia González; Manuel Crespo; Vicenç Falcó; Imma Ocaña; Elisabet Deig; José M Miró; Albert Pahissa
Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
Antiviral therapy 2005;10(5):605-14.
2004: Oscar Miró; Sònia López; M Luisa Rodríguez de la Concepción; Esteban Martínez; Enric Pedrol; Glòria Garrabou; Marta Giralt; Francesc Cardellach; José M Gatell; Francesc Vilarroya; Jordi Casademont
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1550-5.
2004: Eugenia Negredo; Roger Paredes; Joaquim Peraire; Enric Pedrol; Helene Côté; Silvia Gel; Carmina R Fumoz; Lidia Ruiz; Vicente Abril; Eduardo Rodriguez de Castro; Claudia Ochoa; Javier Martinez-Picado; Julio Montaner; Celestino Rey-Joly; Bonaventura Clotet
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.
Antiviral therapy 2004;9(6):889-93.
2004: Oscar Miró; Sònia López; Esteban Martínez; Enric Pedrol; Ana Milinkovic; Elisabet Deig; Glòria Garrabou; Jordi Casademont; José M Gatell; Francesc Cardellach
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):710-6.
2004: Anna Soler; Elisabet Deig; Mònica Vila; Enric Pedrol
[Tuberculous ulcer in the hard palate of a patient with human immunodeficiency virus (HIV) infection].
Enfermedades infecciosas y microbiología clínica 2004;22(7):441-2.
2004: Eugenia Negredo; José Moltó; Jose Munoz-Moreno; Enric Pedrol; Esteban Ribera; Pompeyo E. Viciana; M José Galindos; Celia Miralles; David Burger; Carmina Rodriguez Fumaz; Jordi Puig; Silvia Gel; Eva Rodríguez; Sebastián Videla; Lidia Ruiz; Bonaventura Clotet
Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.
Antiviral therapy 2004;9(3):335-42.
2004: Alfonso Casado; Xavier Badia; Ezequiel Consiglio; Elena Ferrer; Alicia González; Enric Pedrol; José M Gatell; C Azuaje; Josep M Llibre; Miquel Aranda; Pilar Barrufet; Javier Martínez-Lacasa; Daniel Podzamczer
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).
HIV clinical trials 2004;5(3):132-9.
2004: Hernando Knobel; Gabriel Vallecillo; Ana Guelar; Enric Pedrol; Anna Soler; Alexia Carmona; Pere Saballs; Alicia Gonzalez; Juan L Gimeno; José Luis López Colomés
Simplified therapy with zidovudine, lamivudine, and abacavir for very nonadherent, treatment-failing patients.
HIV clinical trials 2004;5(2):65-73.
2004: Sònia López; Oscar Miró; Esteban Martínez; Enric Pedrol; Benjamín Rodríguez-Santiago; Ana Milinkovic; Anna Soler; Miguel A García-Viejo; Virginia Nunes; Jordi Casademont; José M Gatell; Francesc Cardellach
Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
Antiviral therapy 2004;9(1):47-55.
2003: Esteban Martínez; Juan A Arnaiz; Daniel Podzamczer; David Dalmau; Esteban Ribera; Pere Domingo; Hernando Knobel; Melcior Riera; Enric Pedrol; Lluís Force; Josep M Llibre; Ferran Segura; Cristóbal Richart; Cristina Cortés; Manuel Javaloyas; Miquel Aranda; Anna Cruceta; Elisa De Lazzari; José M Gatell
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
The New England journal of medicine 2003;349(11):1036-46.
2003: Oscar Miró; Sònia López; Enric Pedrol; Benjamín Rodríguez-Santiago; Esteban Martínez; Anna Soler; Ana Milinkovic; Jordi Casademont; Virginia Nunes; José M Gatell; Francesc Cardellach
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
Antiviral therapy 2003;8(4):333-8.
2003: Enric Pedrol; María Teresa Alvarez; Elisabet Deig; Inés Andrés; Mónica Ribell; Anna Soler
[Emergencies in patients attender in a drug abuse treatment center].
Medicina clínica 2003;121(1):18-20.
2002: Daniel Podzamczer; Elena Ferrer; Ezequiel Consiglio; José M Gatell; Pepa Perez; José Luis Perez; Elena Luna; Alicia González; Enric Pedrol; Luisa Lozano; Imma Ocaña; Josep M Llibre; Arnaldo Casiró; Miquel Aranda; Pilar Barrufet; Javier Martínez-Lacasa; José M Miró; Xavier Badía; Alfonso Casado; Sergio Lupo; Pedro Cahn; Manel Maños; Jordi Estela
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Antiviral therapy 2002;7(2):81-90.
2001: M G Zaera; Oscar Miró; Enric Pedrol; Anna Soler; M Picón; Francesc Cardellach; Jordi Casademont; Virginia Nunes
Mitochondrial involvement in antiretroviral therapy-related lipodystrophy.
AIDS (London, England) 2001;15(13):1643-51.
2000: Oscar Miró; M Gómez; Enric Pedrol; Francesc Cardellach; Virginia Nunes; Jordi Casademont
Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy.
AIDS (London, England) 2000;14(12):1855-7.
2000: M T Rodellar; E Corona; Anna Soler; A Andreu; L Ramiro; Enric Pedrol
[Changes in emergency visits of patients infected by human immunodeficiency virus since the widespread use of protease inhibitors].
Medicina clínica 2000;115(4):132-4.
1999: O Miró; Josep M Grau; Enric Pedrol
Distinct light microscopic changes in HIV-associated nemaline myopathy.
Neurology 1999;53(1):241-2.
1999: F Olid; A Marcas; A Andreu; Enric Pedrol
[Family medicine residents and hospital emergencies].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 1999;23(4):252-3.
1999: A Marcas; Enric Pedrol; E Llargués; M Bernet
[Colon involvement as a form of presentation of visceral leishmaniasis in an AIDS patient].
Enfermedades infecciosas y microbiología clínica 1999;17(2):102-3.
1998: Ferran Masanés; Antoni Barrientos; Mireia Cebrián; Enric Pedrol; Oscar Miró; Jordi Casademont; Josep M Grau
Clinical, histological and molecular reversibility of zidovudine myopathy.
Journal of the neurological sciences 1998;159(2):226-8.
1997: Oscar Miró; Enric Pedrol; Mireia Cebrián; Ferran Masanés; Jordi Casademont; J Mallolas; Josep M Grau
Skeletal muscle studies in patients with HIV-related wasting syndrome.
Journal of the neurological sciences 1997;150(2):153-9.
1997: Oscar Miró; Mireia Cebrián; Montserrat Laguno; Enric Pedrol; Jordi Casademont; Josep M Grau
["Multicore" myopathy: report of 5 cases].
Medicina clínica 1997;108(19):739-43.
1997: O Miró; Carme Font; Joaquim Fernández-Solà; Jordi Casademont; Enric Pedrol; Josep M Grau; Alvaro Urbano-Márquez
[Chronic fatigue syndrome: study of the clinical course of 28 cases].
Medicina clínica 1997;108(15):561-5.
1996: Josep M Grau; Oscar Miró; Enric Pedrol; Jordi Casademont; Ferran Masanés; Carmen Herrero; G Haussman; Alvaro Urbano-Márquez
Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.
The Journal of rheumatology 1996;23(11):1921-6.
1996: Carme Font; Oscar Miró; Enric Pedrol; Ferran Masanés; Blanca Coll-Vinent; Jordi Casademont; Maria C Cid; Josep M Grau
Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature.
British journal of rheumatology 1996;35(8):796-9.
1996: Ferran Masanés; Enric Pedrol; Josep M Grau; Blanca Coll-Vinent; Jordi Casademont; O Miró; J Mallolas; Alvaro Urbano-Márquez
Symptomatic myopathies in HIV-1 infected patients untreated with antiretroviral agents--a clinico-pathological study of 30 consecutive patients.
Clinical neuropathology 1996;15(4):221-5.
1996: Maria C Cid; Josep M Grau; Jordi Casademont; Esther Tobías; A Picazo; Blanca Coll-Vinent; Jordi Esparza; Enric Pedrol; Alvaro Urbano-Márquez
Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
Clinical and experimental immunology 1996;104(3):467-73.
1996: Oscar Miró; Enric Pedrol; Jordi Casademont; M García-Carrasco; R Sanmartí; Mireia Cebrián; Josep M Grau
Muscle involvement in rheumatoid arthritis: clinicopathological study of 21 symptomatic cases.
Seminars in arthritis and rheumatism 1996;25(6):421-8.
1996: Enric Pedrol; Ferran Masanés; J Fernández-Solá; M Cofan; Jordi Casademont; Josep M Grau; Alvaro Urbano-Márquez
Lack of muscle toxicity with didanosine (ddI). Clinical and experimental studies.
Journal of the neurological sciences 1996;138(1-2):42-8.
1996: Oscar Miró; Enric Pedrol; S Nogué; F Cardellach
[Severe hyponatremia and hypopotassemia induced by the consumption of Equisetum telmateia].
Medicina clínica 1996;106(16):639.
1995: Oscar Miró; Ferran Masanés; Enric Pedrol; M García-Carrasco; J Mallolas; Jordi Casademont; Josep M Grau
[A comparative study of the clinical and histological characteristics between classic nemaline myopathy and that associated with the human immunodeficiency virus].
Medicina clínica 1995;105(13):500-3.
1995: Pau Pastor; O Miró; Enric Pedrol; F Cardellach
[Pseudothrombocytopenia of 5 years of development].
Anales de medicina interna (Madrid, Spain : 1984) 1995;12(10):516.
1995: C Miret; T Solé; Enric Pedrol; J A Junqué; F Vázquez; A Coca; Alvaro Urbano-Márquez
Visual impairment in a woman with histiocytosis.
Postgraduate medical journal 1995;71(837):425-6.
1995: J Robert; Oscar Miró; Enric Pedrol; F Cardellach
[Palinopsia as a manifestation of migraine associated with other symptoms].
Medicina clínica 1995;105(2):76-7.
1995: Enric Pedrol; Josep M Grau; Jordi Casademont; Maria C Cid; Ferran Masanés; J Fernandez-Sola; Alvaro Urbano-Márquez
Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markers.
Clinical neuropathology 1995;14(3):179-84.
1995: Oscar Miró; Pau Pastor; Enric Pedrol; C Mallofré; Josep M Grau; F Cardellach
[Cerebral vascular complications in Conn's disease: report of two cases].
Neurología (Barcelona, Spain) 1995;10(5):209-11.
1995: C Miret; O Miro; Enric Pedrol; E Gómez-Angelats; J Casademont; J Camp; J Milla; Alvaro Urbano-Márquez
[The demand for emergency medical care by the prison population].
Anales de medicina interna (Madrid, Spain : 1984) 1995;12(4):175-81.
1993: Josep M Grau; Ferran Masanés; Enric Pedrol; Jordi Casademont; J Fernández-Solá; Alvaro Urbano-Márquez
Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Annals of neurology 1993;34(2):206-11.
1993: Xavier Bosch; Enric Pedrol; X Casado; A Urbano-Marquez
Josamycin-induced pedal oedema.
BMJ (Clinical research ed.) 1993;307(6895):26.
1993: J Fernández-Solá; Enric Pedrol; Ferran Masanés; Jordi Casademont; Josep M Grau; Alvaro Urbano-Márquez
[Toxic myopathies: clinical, etiologic, and histologic study of 74 cases].
Medicina clínica 1993;100(19):721-4.
1993: M S Barroso; T Solé; E Moitinho; Enric Pedrol
[Hydrochlorothiazide and non-cardiogenic pulmonary acute edema: presentation of a new case].
Anales de medicina interna (Madrid, Spain : 1984) 1993;10(4):207.
1992: Josep M Grau; Jordi Casademont; Enric Pedrol; Joaquim Fernández-Solà; Francesc Cardellach; N Barros; Alvaro Urbano-Márquez
Chronic fatigue syndrome: studies on skeletal muscle.
Clinical neuropathology 1992;11(6):329-32.
1992: Enric Pedrol; X Bosch; M Q Cardona; A Urbano-Márquez
[Acute psychosis and biperiden].
Medicina clínica 1992;99(2):79.
1992: Enric Pedrol; Ferran Masanés; J Fernández-Solá; T Pumarola; J Camp; Alvaro Urbano-Márquez
[Seroprevalence of human immunodeficiency virus infection at an emergency service of an urban area].
Medicina clínica 1992;98(20):761-3.
1992: Enric Pedrol; Josep Mallolas; J M González-Clemente; José M Miró; A Azón; José M Gatell; A Moreno; Josep Mensa; E Soriano
[Cryptococcosis: presentation of 26 cases].
Medicina clínica 1992;98(10):361-5.
1992: J Fernandez-Sola; Jordi Casademont; Josep M Grau; Francesc Graus; Francesc Cardellach; Enric Pedrol; A Urbano-Marquez
Adult-onset mitochondrial myopathy.
Postgraduate medical journal 1992;68(797):212-5.
1991: R M Marrades; Enric Pedrol; R Estruch; J M Miró
[The ganciclovir treatment of stomach ulcers caused by cytomegalovirus in a patient infected with the human immunodeficiency virus].
Revista clínica española 1991;189(5):246-7.
1991: R Estruch; Enric Pedrol; A Castells; Ferran Masanés; R M Marrades; Alvaro Urbano-Márquez
Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward.
Scandinavian journal of gastroenterology 1991;26(8):819-26.
1991: Ferran Masanés; Enric Pedrol; A de la Sierra; F Martínez-Orozco
[Massive pleural effusion as the first manifestation of acute pancreatitis].
Revista clínica española 1991;189(1):46-7.
1991: Ferran Masanés; Enric Pedrol; J Bladé; Jordi Casademont; A de la Sierra; F Martínez-Orozco; Josep M Grau; M Ingelmo
[IgM myeloma: a report of 2 cases].
Medicina clínica 1991;96(20):777-9.
1991: Enric Pedrol; J Fernández-Solá; M Ferrer; J Barceló; X Bosch; L Sandé; J Camp; A Borrás; Alvaro Urbano-Márquez
[Hemoptysis: a prospective study of 108 cases in an emergency service].
Revista clínica española 1991;188(9):450-4.
1991: Enric Pedrol; R Estruch; R M Marrades; M Ingelmo
[Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
Revista clínica española 1991;188(6):319.
1991: J M González-Clemente; Enric Pedrol; B Sanz; A Azón; José M Miró; Josep Mallolas; Josep Mensa; E Soriano
[Syphilis and human immunodeficiency virus infection: diagnostic and therapeutic problems. Presentation of 2 cases and review of the literature].
Revista clínica española 1991;188(6):288-94.
1990: F Valldeoriola; J Gratacos; Enric Pedrol; A de la Sierra
[Septic arthritis due to Pasteurella multocida].
Revista clínica española 1990;187(7):368-9.
1990: J M González-Clemente; José M Miró; Enric Pedrol; R Alvarez; José M Gatell; Josep Mallolas; Francesc Graus; J M Mercader; Ana Guelar; M Teresa Jiménez de Anta
[Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
Medicina clínica 1990;95(12):441-6.
1990: Enric Pedrol; J M González-Clemente; José M Gatell; Josep Mallolas; José M Miró; Francesc Graus; R Alvarez; J M Mercader; J Berenguer; M Teresa Jiménez de Anta
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.
AIDS (London, England) 1990;4(6):511-7.
1990: A Castells; M Q Cardona; Enric Pedrol; M Navarro; J Casademont; Antonio Coca
[Toxic megacolon and intestinal perforation caused by Salmonella enteritidis].
Revista clínica española 1990;186(7):332-4.
1989: A Azon-Masoliver; J Gonzalez-Clemente; Enric Pedrol; Mario Lecha; Josep Mensa; JM Mascaro
Herpetiform and mollusca contagiosa-like cutaneous cryptococcosis in a patient with AIDS.
The British journal of dermatology 1989;121(5):665-7.